Medtronic develops and manufactures innovative medical device technologies and therapies to treat chronic diseases worldwide.

Medical Devices

Medtronic

Ms. Fonseca serves on the Compensation Committee and Science and Technology Committee of the Board.

Ms. Fonseca has more than 30 years of experience in healthcare innovation. In her current role, she is responsible for developing and implementing an enterprise-wide digital strategy, leading all digital, data and technology solutions across the company. She is also responsible for [Pfizer](/org/pfizer) Learning and Development and Business Process Excellence.

Ms. Fonseca also spearheads several innovative programs and initiatives, including those that digitize drug discovery and development; improve health outcomes and patient experiences through digital health, medicines, and diagnostics; advance operational processes through automation and robotics; and deliver powerful insights with advanced analytics and artificial intelligence (AI) for better decision-making.

Most recently, she led [Pfizer](/org/pfizer)'s digital team as the company made critical efforts to help accelerate the development of a COVID-19 vaccine in less than a year. She also led the efforts to create [Pfizer](/org/pfizer)'s Advanced Analytics Platform that combines data and tools from [Pfizer](/org/pfizer) and its external partners to model scientific and clinical decisions, patterns, and insights.

Prior to her current role, from 2014 to 2018, Ms. Fonseca was the Senior Vice President and CIO at [Quest Diagnostics](/org/quest-diagnostics), the world's leading provider of diagnostic information services, where she was responsible for technology, informatics, and digital solutions. Prior to that she served as the Senior Vice President and Chief Information Officer at Labcorp from 2008 to 2013.

Throughout her career, Ms. Fonseca has received several awards and accolades, including being named on the 2022 Forbes CIO Next List recognizing the top 50 tech leaders who are redefining the CIO role and driving game-changing innovation. She was recognized as one of the 50 Most Powerful Latinas in 2020 and 2021 by the Association of Latino Professionals for America, as well as a 2020 Healthcare Influencer and 2019 Healthcare Transformer by Medical, Marketing & Media. She has received the Forbes CIO Innovation Award in 2017 and currently serves on the U.S.-Japan Business Council.

Lidia Fonseca

Jennifer Kirk is currently the Global Controller & Chief Accounting Officer at [Medtronic](/org/medtronic). Prior to this, they were with [Republic Services](/org/republic-services) as the SVP - Integration & Value Capture from July 1999 to December 2020. Jennifer also has experience with Arthur Andersen & Co. where they worked as an accountant from September 1996 to June 1999.

Jennifer Kirk has a MBA in Business Administration from California State University, Bakersfield and a BA in Economics with an emphasis in Accounting from [UC Santa Barbara](/org/uc-santa-barbara).

Jennifer Kirk works with Laura Mauri - SVP, Chief Clinical & Regulatory Officer, Richard E. Kuntz - SVP, Chief Medical & Scientific Officer, and Alex Gu - SVP & President, Greater China. Jennifer Kirk reports to Geoffrey S. Martha, President & CEO.

Jennifer Kirk

Mr. Lofton served as the Chief Executive Officer of CommonSpirit Health from February 2019, following the merger between Catholic Health Initiatives and [Dignity Health](/org/dignity-health), until his retirement in June 2020.  Mr. Lofton previously served as the Chief Executive Officer of Catholic Health Initiatives from 2003 to 2019, and also held various executive management roles with Catholic Health Initiatives beginning in 1998.  Mr. Lofton has also served as the Executive Director and Chief Executive Officer from 1993 to 1998 at UAB Hospital and from 1990 to 1993 at Howard University Hospital, as well as the Executive Vice President and Chief Operating Officer of University Medical Center, Jacksonville, Florida, now known as [UF Health](/org/uf-health) - Jacksonville from 1986 to 1990.  



Kevin E. Lofton

Mr. Hogan is Chairman of nVent Electric plc, a manufacturing company for electrical connection and protection products since May 2018. He was previously the Chief Executive Officer of [Pentair](/org/pentair) plc, an industrial manufacturing company, from 2001 until 2018 and served as Chairman from 2002 until 2018. From December 1999 to December 2000, he was President and Chief Operating Officer of [Pentair](/org/pentair), from March 1998 to December 1999 he was Executive Vice President and President of [Pentair](/org/pentair)’s Electrical and Electronic Enclosures Group. Prior to joining [Pentair](/org/pentair), he was President of the Carrier Transicold Division of United Technologies Corporation. Before that, he was with the [Pratt & Whitney](/org/pratt-whitney) division of United Technologies, General Electric Company and [McKinsey & Company](/org/mckinsey-company). Mr. Hogan served as Chairman of the board of the [Federal Reserve Bank of Minneapolis](/org/federal-reserve-bank-of-minneapolis) from December 2013 until January 2016. Mr. Hogan is a former director of Covidien plc and [Pentair](/org/pentair) plc.

Randall J. Hogan III

Dr. Austin L. Chiang is a medical doctor and currently serves as the Chief Medical Officer of Gastrointestinal at [Medtronic](/org/medtronic). Austin has also worked as a medical writer and research fellow in gastroenterology. Dr. Chiang completed their residency in internal medicine at Columbia University Medical Center and New York Presbyterian Hospital. Austin then went on to complete fellowships in both bariatric endoscopy and advanced endoscopy.

Austin L. Chiang has a Master of Public Health from Harvard T.H. Chan School of Public Health, an MD from Columbia University Vagelos College of Physicians and Surgeons, and a B.S. from [Duke University](/org/duke-university). Austin also has certification from the [American Board of Internal Medicine](/org/american-board-of-internal-medicine) in Board Certification in Gastroenterology and Board Certification in Internal Medicine, as well as certification from the American Board of Obesity Medicine in Board Certification in Obesity Medicine.

Their manager is Giovanni Di Napoli, President, Gastrointestinal.

Austin L. Chiang

Ivan Fong is currently the EVP, General Counsel & Secretary at [Medtronic](/org/medtronic). Ivan has previously served as Executive Vice President, Chief Legal and Policy Officer and Secretary at Cboe Global Markets, and as General Counsel at the [U.S. Department of Homeland Security](/org/the-department-of-homeland-security). Prior to that, they were CLO & Secretary at [Cardinal Health](/org/cardinal-health), SVP & General Counsel at GE Vendor Financial Services, and Sr. Counsel, E-Commerce & IT at GE. Mr. Fong began their career as a Deputy Associate Attorney General at the U.S. Department of Justice, before becoming a Partner at Covington & Burling. Ivan then served as a Law Clerk for Justice Sandra Day O'Connor at the [Supreme Court of the United States](/org/supreme-court-of-the-united-states).

Ivan Fong is a graduate of Stanford Law School, the [University of Oxford](/org/university-of-oxford), and the Massachusetts Institute of Technology. Ivan has a Juris Doctor degree from Stanford, a Bachelor of Civil Law degree from Oxford, and a Master of Science degree in Chemical Engineering Practice from MIT. Ivan also has a Bachelor of Science degree in Chemical Engineering from MIT.

Ivan Fong reports to Geoffrey S. Martha, President & CEO. They work with Richard E. Kuntz - SVP, Chief Medical & Scientific Officer, Carol Surface - SVP, CHRO, and Noel Colón - SVP, Chief Quality Officer.

Ivan Fong

Giovanni Di Napoli is the current President of Gastrointestinal at [Medtronic](/org/medtronic). Prior to this, they held various positions at [Medtronic](/org/medtronic), BÂRRX Medical, and [Johnson & Johnson](/org/johnson-johnson). Giovanni has been in the medical industry for over 15 years and has experience in sales, marketing, business development, product development, and trade show representation. Giovanni has also been responsible for sales training and forecasting.

Giovanni Di Napoli is a [Harvard Business School](/org/harvard-business-school) graduate who also has an MBA from [SDA Bocconi](/org/sda-bocconi) and an Executive MBA from Università Bocconi. Giovanni is currently a leading figure in global business and international/global studies.

Giovanni Di Napoli reports to Robert J. White, EVP & President, Medical Surgical Portfolio. and Austin L. Chiang - Chief Medical Officer, Gastrointestinal reports to Giovanni Di Napoli.

Giovanni Di Napoli

Noel Colón is Senior Vice President, Chief Quality Officer at [Medtronic](/org/medtronic). In this role, Noel oversees all global quality operations for the company and is a member of the [Medtronic](/org/medtronic) Executive Committee.

He partners with the business groups and global regions to assure end-to-end quality and reliability from development through manufacturing, distribution, and end-customer use. He is responsible for driving the strategic direction for the quality programs through the implementation of policy and standards across [Medtronic](/org/medtronic). He joined [Medtronic](/org/medtronic) in March 2008 as senior director of Manufacturing and Supplier Quality for Cardiac Rhythm Disease Management (CRDM). Most recently, Noel served as vice president of quality for the Restorative Therapies Group (RTG) from 2017-2019. Prior to this role, he was the vice president of [Medtronic](/org/medtronic) Energy and Component Center (MECC) and CRDM pharmaceutical operations from 2012-2017. From 2011-2012, he served as vice president of manufacturing and supplier quality for the Cardiac and Vascular Group (CVG). 

Noel was the recipient of the 2016 [Medtronic](/org/medtronic) Compass Award for ethics and compliance. 

Previously, Noel spent 17 years at Boston Scientific CRM (Guidant), where he held several leadership roles in manufacturing, process development and quality for the cardiac rhythm management division at Minnesota, Ireland and Puerto Rico.  

Noel serves as founding member of the [Medtronic](/org/medtronic) Hispanic Latino Network — an internal resource group that focuses on recruitment, engagement, retention and development for employees of Hispanic Latino descent.

Noel received his Bachelor of Science degree in Mechanical Engineering from the University of Puerto Rico, Mayagüez Campus and his Master of Business Administration from InterAmerican University of Puerto Rico.

Noel Colón

Sophia Denton

Abby Shai

Abhishek Sood

Mr. Arnold has been Chairman and Chief Executive Officer of Eaton Corporation, a power management company, since June 1, 2016. From September 2015 to May 2016, Mr. Arnold served as President and Chief Operating Officer of Eaton Corporation. Prior to that, Mr. Arnold served as the Vice Chairman and Chief Operating Officer, Industrial Sector, of Eaton Corporation. From 2000 to 2008 he served as Senior Vice President of Eaton Corporation and Group Executive of the Fluid Power Group of Eaton. Prior to joining Eaton, Mr. Arnold was employed in a series of progressively more responsible positions at General Electric Company from 1983 to 2000. Mr. Arnold was appointed to the Board of Directors of Eaton Corporation in 2015. Mr. Arnold is a former Director of Covidien plc.

Craig Arnold

Dr. Goldsmith has served as the Stephen Harris professor in the School of Engineering at [Stanford University](/org/stanford) since 2012 and is director of Stanford’s Wireless Systems Laboratory. She has served as a professor, associate professor or assistant professor at [Stanford University](/org/stanford) since January 1999. Dr. Goldsmith co-founded and served as Chief Technology Officer of Plume WiFi (formerly, Accerlera, Inc.) from August 2010 to August 2014 and Quantenna Communications, Inc. (formerly, mySource Communications, Inc.) from 2005 to 2009 and previously held positions at Maxim Technologies, MemoryLink Corporation and AT&T Bell Laboratories.

Previously, she was an assistant professor of Electrical Engineering at the [California Institute of Technology](/org/california-institute-of-technology). Dr. Goldsmith currently serves on the Board of Directors for Crown Castle International Corp. She is also co-principal investigator for the NSF Center for Science of Information and is on the technical advisory boards of [Sequans Communications](/org/sequans-communications) and [Cohere Technologies](/org/cohere-technologies). She is a member of the National Academy of Engineering and the American Academy of Arts and Sciences and a Fellow of the Institute of Electrical and Electronics Engineers. Dr. Goldsmith is a frequent lecturer and writer regarding wireless technologies.

Andrea Goldsmith

Chris Lee (李希烈) is Senior Vice President and President of [Medtronic](/org/medtronic) Asia Pacific (APAC). Chris joined [Medtronic](/org/medtronic) in 2012 as president of the Greater China region. Under his leadership, the region achieved five consecutive years of double-digit growth by bringing meaningful innovation and expanding access to more patients in China.

Chris has a strong track record of global leadership in the healthcare industry — both in pharmaceutical and medical technology. He is known for his inclusive leadership style, commitment to meritocracy, and proven business success. During his time in China, Chris developed strategic partnerships with the Chinese government and was a strong supporter of corporate social responsibility —  leading the company’s effective relief efforts to respond to the Lushan earthquake in Sichuan Province.

Prior to [Medtronic](/org/medtronic), Chris was Regional Head and Senior Vice President, Asia Pacific at Bayer HealthCare where he was responsible for overall operations in the region, including pharmaceuticals, consumer over the counter, animal health, and medical devices. Chris has also held roles of increasing responsibility in a number of multinational companies, including Bristol Myers Squibb and Merck Sharpe and Dohme, while based in Asia Pacific and the U.S., respectively.

Chris is a pioneer in the management of workplace happiness and is the author of two best-selling books, one on emotional management and one on marketing. He was also formerly an executive director in the pharmaceutical industry associations of China (RDPAC), Australia (Medicines Australia), and Korea (Korea Pharma).

Chris serves on the board of the Asia Pacific Medical Technology Association (APACMed).

Chris holds a bachelor's degree from the University of Arizona, Tucson and a master’s degree from the American Graduate School of International Management (Thunderbird). He is fluent in English and Korean, with a good understanding of Mandarin Chinese and Japanese.

Chris Lee

Geoff Martha is Chief Executive Officer of [Medtronic](/org/medtronic), the world’s leading medical technology company, with $30 billion in annual revenue, more than 90,000 employees, and operations reaching more than 150 countries worldwide. [Medtronic](/org/medtronic) offers technologies and solutions to treat a wide range of medical conditions, including cardiac and vascular diseases, respiratory, neurological and spinal conditions, diabetes, and more. Geoff also serves as a member of the [Medtronic](/org/medtronic) Board of Directors, a role he has had since November 2019.

Geoff assumed the role of CEO on April 27, 2020, and reports to the [Medtronic](/org/medtronic) Board of Directors. He served as President of [Medtronic](/org/medtronic) from November 2019 through April 2020, leading [Medtronic](/org/medtronic)’s operating groups and regions.

Prior to being announced as [Medtronic](/org/medtronic)’s new CEO, Geoff served as Executive Vice President and President of [Medtronic](/org/medtronic)’s Restorative Therapies Group (RTG). In that position, Geoff had global responsibility for RTG’s four divisions, including Brain Therapies, Pain Therapies, Specialty Therapies, and Spine.

Prior to leading RTG, Geoff was Senior Vice President of Strategy and Business Development for [Medtronic](/org/medtronic) and was responsible for leading the development of [Medtronic](/org/medtronic)'s global strategic plan, business development and acquisition-integration.

As head of Strategy and Business Development, Geoff led the acquisition of Covidien, a $10 billion global manufacturer of surgical products and supplies. The acquisition of Covidien was the largest medical technology acquisition in the history of the industry. In July 2014, he was named Chief Integration Officer to lead the integration of Covidien into [Medtronic](/org/medtronic).

An ardent supporter of [Medtronic](/org/medtronic)-sponsored philanthropic and diversity initiatives, Geoff is a member of the [Medtronic](/org/medtronic) Foundation Board of Directors and serves as [Medtronic](/org/medtronic)’s Executive Sponsor to FIRST Robotics. He also led the [Medtronic](/org/medtronic) African Descent Network ― an internal resource group that focuses on recruitment, engagement, retention and development for employees of African descent.

Prior to joining [Medtronic](/org/medtronic), Geoff served as Managing Director of Business Development at [GE Healthcare](/org/ge-healthcare-limited), where he was responsible for global business development, including acquisitions, divestitures, joint ventures and equity investments. In his 19-year career with GE, which included significant time with GE Capital, Geoff held several executive roles in business leadership, corporate development, strategic marketing, and sales management.

Passionate about socio-economic issues, Geoff serves on the boards of two Minneapolis-based nonprofit organizations: Children’s HeartLink and Northside Achievement Zone (NAZ). Children’s HeartLink provides access to care for children around the world with congenital heart defects. NAZ is a community collaborative that works to end generational poverty and build a culture of achievement in North Minneapolis so low-income children of color graduate college and are career-ready.

Geoff received a bachelor’s degree in Finance as a member of the Scholar’s Program from Pennsylvania State University. He graduated in 1992 with highest honors. Geoff was captain of the Penn State men’s hockey team and was inducted into its Hockey Hall of Fame in 1998. The University awarded him the 2016 Penn State Hockey Distinguished Alumni Award. He is also a member of Penn State’s College of Liberal Arts Development Council.


Geoffrey S. Martha

Dr. Rick Kuntz is Senior Vice President, Chief Medical and Scientific Officer of [Medtronic](/org/medtronic) and serves as a member of the Company’s Executive Committee. In this role, Kuntz oversees the company’s medical affairs, health policy and reimbursement, clinical research activities, and corporate technology.

Kuntz joined [Medtronic](/org/medtronic) in October 2005, as Senior Vice President and President of [Medtronic](/org/medtronic) Neuromodulation, which encompasses the company’s products and therapies used in the treatment of chronic pain, movement disorders, spasticity, overactive bladder and urinary retention, benign prostatic hyperplasia, and gastroparesis. In this role he was responsible for the research, development, operations and product sales and marketing for each of these therapeutic areas worldwide.

Kuntz brings to [Medtronic](/org/medtronic) a broad background and expertise in many different areas of healthcare. Prior to [Medtronic](/org/medtronic) he was the Founder and Chief Scientific Officer of the Harvard Clinical Research Institute (HCRI), a university-based contract research organization which coordinates [National Institutes of Health](/org/national-institutes-of-health) (NIH) and industry clinical trials with the United States Food and Drug Administration (FDA). Kuntz has directed over 100 multicenter clinical trials and has authored more than 250 original publications. His major interests are traditional and alternative clinical trial design and biostatistics.

Kuntz also served as Associate Professor of Medicine at Harvard Medical School, Chief of the Division of Clinical Biometrics, and an interventional cardiologist in the division of cardiovascular diseases at the Brigham and Women’s Hospital in Boston, MA. Kuntz has served as a member of the Board of Governors of PCORI (Patient Centered Outcomes Research Institute) since it was established in 2010 as part of the Affordable Care Act.

Kuntz graduated from Miami University, and received his medical degree from Case Western Reserve University School of Medicine. He completed his residency and chief residency in internal medicine at the University of Texas Southwestern Medical School, and then completed fellowships in cardiovascular diseases and interventional cardiology at the Beth Israel Hospital and Harvard Medical School, Boston. Kuntz received his Master’s of science in biostatistics from the Harvard School of Public Health.

Richard E. Kuntz

Que Dallara serves as Executive Vice President and President for the Diabetes Operating Unit (OU). In this role, Que is responsible for the overall strategic direction of the Diabetes OU and its day-to-day global operations.

Que joined [Medtronic](/org/medtronic) in May 2022. Most recently, she served as President and CEO of [Honeywell](/org/honeywell) Connected Enterprise, [Honeywell](/org/honeywell)’s software business. Prior to that, she was SVP and chief commercial officer of [Honeywell](/org/honeywell), leading the company’s efforts in strategy, marketing, sales excellence, pricing, product innovation, including enterprise software, data analytics and IoT solutions.

Before [Honeywell](/org/honeywell), Que served in roles with increasing responsibility from general management to business development at [TE Connectivity](/org/te-connectivity), a global leader in connectivity and sensor solutions. As Senior Vice President, Corporate Strategy and Analytics, she led the strategic growth process, performance management of business units and big data analytics.

Prior to that, Que worked at Microsoft as Senior Director, Strategy, M&A, Integration and Governance for the Consumer Software & Services division. She has also held positions at itv|world, Telstra Corporation and [McKinsey & Company](/org/mckinsey-company).

Experienced in new product development and commercialization, Que has managed robust product portfolios, led end-to-end R&D innovation, and business development initiatives that strengthened organic and inorganic company growth. 

Que earned a Bachelor of Science in Applied Mathematics, a Bachelor of Commerce in Finance at the University of New South Wales, Australia, and an MBA at [INSEAD](/org/insead) in France. 

Que Dallara

Laura Mauri, M.D., M.Sc., is the Senior Vice President, Chief Clinical and Regulatory Officer, at [Medtronic](/org/medtronic).  In this role, Laura leads [Medtronic](/org/medtronic)’s global clinical research and regulatory affairs functions and is a member of the [Medtronic](/org/medtronic) Executive Committee.

Laura joined [Medtronic](/org/medtronic) in September of 2018, in the role of Vice President of Global Clinical Research and Analytics.  Laura has been the executive sponsor of the company’s Clinical Research Council that convenes [Medtronic](/org/medtronic)’s global clinical research leaders across all product areas, and led the company’s clinical trial response and mitigation plans for COVID-19. She has also been responsible for leading the development of novel analytical and data science solutions to provide global clinical evidence for [Medtronic](/org/medtronic) products.  

Laura was a practicing interventional cardiologist at the Brigham and Women’s Hospital for 15 years.  An internationally renowned investigator and Professor of Medicine at Harvard Medical School, Laura helped shape clinical evaluation of new medical technology, providing a greater understanding of the interactions between medical devices, clinical practice, and concurrent pharmaceutical therapy.  An expert in trial design, strategy and data analysis, she led numerous clinical trials to evaluate novel medical devices and pharmaceuticals, and held an array of major leadership positions, serving as the Chief Scientific Advisor for the Harvard Clinical Research Institute. 

Laura received her A.B. from Harvard College and her M.D. from Harvard Medical School, both magna cum laude, and her M.Sc. (Clinical Epidemiology) from Harvard School of Public Health.  She completed residency in internal medicine and fellowships in cardiovascular disease and interventional cardiology at the Brigham and Women’s Hospital.

Laura is a member of the American Society of Clinical Investigation, the Association of University Cardiologists, a Fellow of the American College of Cardiology, a Fellow of the American Heart Association and American College of Cardiology, and member of the Society of Cardiac Angiography and Intervention.  She has authored approximately 200 original articles, served as a Senior Editor for the journal Circulation, and was awarded the Joseph A. Vita Award for Clinical Research by the American Heart Association in 2017.

Laura Mauri

EMAN ALY

Sean Salmon serves as Executive Vice President and President for the Cardiovascular Portfolio.

In this dual role, Sean is responsible for the overall strategic direction of the Diabetes OU and its day-to-day global operations. He is also responsible for optimizing [Medtronic](/org/medtronic) enterprise performance by supporting capital allocation, talent management, investments, and collaboration to create value across all eight OUs that are organized under the Cardiovascular Portfolio, in addition to the Diabetes OU.

Sean joined [Medtronic](/org/medtronic) in 2004 and has held increasingly senior management roles. Most recently as President of Coronary & Structural Heart within our Cardiovascular Portfolio, he led numerous functions including Clinical, Regulatory, R&D, Quality, Health Economics & Reimbursement, Business Development and Strategy. He led [Medtronic](/org/medtronic)’s entry into the highly-competitive drug eluting stent market and subsequently diversified the business via organic innovation and acquisitions. He also led the expansion of [Medtronic](/org/medtronic)’s fast-growing transcatheter valve replacement (TAVR) business by commercializing multiple product innovations, extending global penetration and by expanding treatment indications.

Sean has nearly 30 years’ experience in the medical device and pharmaceutical industries, with previous roles at C.R. Bard, [Johnson & Johnson](/org/johnson-johnson), SurgiVision and EuroRSCG Life. He earned an MBA from the Kellogg School of Management at [Northwestern University](/org/northwestern-university) and a BS in Applied Physiology from [Boston University](/org/boston-university).

Sean Salmon

Nancy Umuhire

Robert J. White is the executive vice president and president of the medical surgical portfolio at [Medtronic](/org/medtronic). Robert has held various other positions in the medical field throughout their career. These positions include president of emerging markets at Covidien, vice president and general manager of diagnostic imaging at [GE Healthcare](/org/ge-healthcare-limited), and president at Merge Healthcare. Robert has also served as the chief operating officer of SourceOne Healthcare Technologies and the senior vice president of sales and marketing at Accelrys.

Robert J. White obtained their Bachelor's degree in Marketing from [Cleveland State University](/org/cleveland-state-university). Robert then went on to obtain their MBA in Finance from the Weatherhead School of Management at [Case Western Reserve University](/org/case-western-reserve-university).

A direct report to Robert J. White is and Giovanni Di Napoli - President, Gastrointestinal. Robert J. White reports to Geoffrey S. Martha, President & CEO. Robert J. White works with Laura Mauri - SVP, Chief Clinical & Regulatory Officer, Alex Gu - SVP & President, Greater China, and Noel Colón - SVP, Chief Quality Officer.

Robert J. White

Brett Wall is Executive Vice President and President of [Medtronic](/org/medtronic)’s Neuroscience Portfolio that is comprised of five unique Operating Units—Neuromodulation, Cranial & Spinal Technologies, Neurovascular, Pelvic Health and Ear, Nose and Throat. Together, these Operating Units generate over $8B in annual revenue and employ approximately 15,000 employees worldwide. Brett also serves as a member of the company’s Executive Committee.

Previously, he was Senior Vice President of the legacy Brain Therapies division which is part of the Neuroscience portfolio.

Brett has global responsibility for RTG’s four divisions, which include Brain Therapies, Pain Therapies, Specialty Therapies and Spine. He provides overall strategic direction and operational management, as well as leads the integration of the group’s activities within the overall strategy of [Medtronic](/org/medtronic). Previously, he was Senior Vice President of the Brain Therapies division in RTG.

Brett also serves as the Executive Sponsor of the [Medtronic](/org/medtronic) African Descent Network — an internal national resource group that focuses on recruitment, engagement, retention and development for employees of African descent.

Prior to the [Medtronic](/org/medtronic) acquisition of Covidien, Brett served as Covidien President, Neurovascular and International, where he managed all commercial activities and functions of the business resulting in a doubling of revenue during his tenure.

He also served as Senior Vice President and President, Neurovascular; and Senior Vice President and President, International, at ev3, Inc. Prior to the ev3 merger with Micro Therapeutics, Brett held the positions of Micro Therapeutic Vice President, Marketing, for the Neurovascular and Peripheral Vascular divisions.

Brett’s career journey also included work at Boston Scientific as the Director of Marketing, Cardiovascular, Asia Pacific; and Marketing Manager, Japan, where he was responsible for the Interventional Cardiology product lines within the Asia-Pacific region. In addition, he held positions of increasing responsibility at C.R. Bard, where he was responsible for marketing the company’s suite of urological products.

Brett currently serves on the board executive committee for OCTANe, a group that promotes technical growth and expertise in the greater Orange County, California area. He also is a member of the CEO Roundtable at the University of California, Irvine. Previously, Brett served as Chairman of the Heart and Stroke Ball for the American Heart Association, Orange County Chapter.

Brett earned his bachelor’s degree in Comprehensive Business Administration with an emphasis in Marketing from the University of Nebraska at Kearney. He is a resident of Southern California.

Brett Wall

Torod Neptune is Senior Vice President and Chief Communications Officer of Medtronic. He serves on the company’s Executive Committee and is responsible for leading the Global Communications and Corporate Marketing organization. In this role, he oversees the company’s external, internal and executive communications, brand, crisis and issues management, digital marketing, sponsorships, content marketing, social media and more. He also serves as chair of the company’s Marketing Leadership Council—helping drive the company’s growth by enabling best-in-class marketing. 

Torod joined Medtronic in February 2021 from Lenovo Group, Ltd. where he was Worldwide Group Vice President and Chief Communications Officer. At Lenovo, he was responsible for global brand and product communications for Lenovo PCs, smart devices and tablets and Motorola smart phones. He was also in charge of the company’s global integrated communications and played a pivotal role on the Lenovo executive team that drove the company’s business and culture transformation.

He is a seasoned global leader who was named to PR Week’s 2020 Power List of 50 most influential and impactful communications professionals. He has a proven track record of managing complex brand, reputation, public policy, and issues for large global businesses in highly competitive and regulated industries in both direct-to-consumer and business-to-business companies.

Torod held communications leadership roles at Verizon and Bank of America, and served as a Chief Communications Strategist for the U.S. House of Representatives. He has experience at some of the leading communications agencies working on major healthcare/pharma brands, including Abbott, GSK, Philips Healthcare and Shire/Takeda. He started his career as a journalist.

Torod serves on the board of directors for The LAGRANT Foundation, an organization dedicated to increasing the number of ethnic minorities in the fields of advertising, marketing, and public relations through scholarships, professional development, mentors, and internships.

He is a member of the Board of Visitors for the University of Southern California’s Annenberg School of Communications and Journalism, and of the Board of Advisers for the University of North Carolina at Chapel Hill’s Hussman School of Journalism and Media.

Torod earned his bachelor’s degree in Government and International Affairs & Journalism, Global Affairs/Soviet and Middle Eastern Foreign Policy from the University of South Carolina.

Torod Neptune

Jonathan Bax

Greg Smith is Executive Vice President, Global Operations and Supply Chain at [Medtronic](/org/medtronic). He is responsible for the performance and integration of all aspects of the company’s operations including Manufacturing, Supply Chain, Supply Management, Operational Excellence and Transformation, Enterprise Risk and Facilities, and Operations Quality.

Before joining [Medtronic](/org/medtronic) in April 2021, Greg was the Executive Vice President of U.S. Supply Chain at [Walmart](/org/walmart), one of the world’s largest and most complex supply chains. Greg transformed [Walmart](/org/walmart)’s supply chain to be best-in-class, developing and implementing a comprehensive strategy that drove sales, achieved operational excellence, reduced costs and created an engaging, enabling and empowering work environment.

Greg is deeply committed to diversity, equality, and the belief that a diverse workplace where everyone feels included results in stronger teams and the highest level of service to our patients, customers and employees. He was recognized as a 2020 Diversity Leader by Diversity Journal(opens new window).

Before joining [Walmart](/org/walmart), Greg was Senior Vice President, Global Operations at The [Goodyear](/org/goodyear) Tire & Rubber Company, responsible for 52 manufacturing facilities across four business units around the world. He successfully led the company’s global optimization program and implemented an enterprise manufacturing operating system, a global procurement program and an enterprise planning and logistics approach. With more than 30 years of supply chain and operations experience, Greg has transformed manufacturing, procurement and logistics programs at companies like [Goodyear](/org/goodyear), ConAgra Foods, United Signature Foods, VDK Frozen Foods and Quaker Oats.

Greg earned his bachelor’s degree in finance from the University of Tennessee – Knoxville. He currently serves on the Global Supply Chain and College of Business advisory boards at the University of Tennessee.

Greg Smith

Greg Dameron

Carol Surface is currently the SVP, CHRO at [Medtronic](/org/medtronic). Carol has previously served as the Executive Vice President, Chief Human Resources Officer at [Best Buy](/org/best-buy) from March 2010 to September 2013, and as the Chief Personnel Officer - Asia, Middle East, Africa at [PepsiCo](/org/pepsico) from January 2000 to February 2010.

Carol Surface has a PhD in Industrial and Organizational Psychology from [Central Michigan University](/org/central-michigan-university), and a BA in Psychology from Castleton University.

They work with Torod Neptune - SVP, Chief Communications Officer, Richard E. Kuntz - SVP, Chief Medical & Scientific Officer, and Chris Lee - SVP & President, APAC. Carol Surface reports to Geoffrey S. Martha, President & CEO.

Medtronic

Org chart

Teams

CEO and Executive Team

Leadership Team

Board of Directors

Discover similar companies